Recent advances in estrogen receptor antagonists
Lloyd, D.G.; Meegan, M.J.
Idrugs the Investigational Drugs Journal 3(6): 632-642
2000
ISSN/ISBN: 1369-7056 PMID: 16096926 Document Number: 512354
Document emailed within 1 workday
Related Documents
Ferguson, A.T.; Lapidus, R.G.; Baylin, S.B.; Davidson, N.E. 1995: Demethylation of the estrogen receptor gene in estrogen receptor-negative breast cancer cells can reactivate estrogen receptor gene expression Cancer Research 55(11): 2279-2283Kahán, Z. 1996: Current questions about estrogen receptor determination and hormone dependence (does estrogen receptor positivity equal estrogen dependence?) Orvosi Hetilap 137(42): 2305-2308
Nizamutdinova, I.T.; Lee, G.W.; Son, K.H.; Jeon, S.J.; Kang, S.S.; Kim, Y.S.; Lee, J.H.; Seo, H.G.; Chang, K.C.; Kim, H.J. 2008: Tanshinone i effectively induces apoptosis in estrogen receptor-positive (MCF-7) and estrogen receptor-negative (MDA-MB-231) breast cancer cells International Journal of Oncology 33(3): 485-491
Castles, C.G.; Fuqua, S.A.; Klotz, D.M.; Hill, S.M. 1993: Expression of a constitutively active estrogen receptor variant in the estrogen receptor-negative BT-20 human breast cancer cell line Cancer Research 53(24): 5934-5939
Horwitz, K.B.; McGuire, W.L. 1978: Estrogen control of progesterone receptor in human breast cancer. Correlation with nuclear processing of estrogen receptor Journal of Biological Chemistry 253(7): 2223-2228
Kotula-Balak, M.; Gancarczyk, M.; Sadowska, J.; Bilinskai, B. 2005: The expression of aromatase, estrogen receptor alpha and estrogen receptor beta in mouse Leydig cells in vitro that derived from cryptorchid males European Journal of Histochemistry: Ejh 49(1): 59-62
Masiuk, M. 2006: Expression and intranuclear distribution of nucleolin in estrogen receptor-negative and estrogen receptor-positive breast cancers in women measured by laser scanning cytometry Annales Academiae Medicae Stetinensis 52(2): 23-32
Echeverría, O.M.; Thampan, R.V.; Juárez-Chavero, S.; Hernández-Pérez, A.D.; Ortiz, R.; Vázquez-Nin, G.H. 2005: Immunocytochemical study of estrogen receptor activation factor (E-RAF) and the proteins that interact with nuclear estrogen receptor II (nER II) in epithelial endometrial cells, in the presence and in the absence of estradiol European Journal of Histochemistry: Ejh 49(1): 67-74
Shiozawa, T.; Itoh, K.; Horiuchi, A.; Konishi, I.; Fujii, S.; Nikaido, T. 2002: Down-regulation of estrogen receptor by the methylation of the estrogen receptor gene in endometrial carcinoma Anticancer Research 22(1a): 139-143
Wang, S.-l.; Li, Y.-x.; Song, Y.-w.; Wang, W.-h.; Jin, J.; Liu, Y.-p.; Liu, X.-f.; Yu, Z.-h. 2010: Prognostic value of estrogen receptor, progesterone receptor and human epidermal growth factor receptor-2 in node positive breast cancer patients treated by mastectomy Zhonghua Zhong Liu Za Zhi 32(7): 520-525
Fondo, E.Y.; Menendez-Botet, C.J.; Schwartz, M.K.; Whitmore, W.F. 1981: Estrogen binding and estrogen receptor activity in the human prostate: a preliminary report Journal of the National Medical Association 73(3): 261-266
Takano, N.; Kimura, J.; Okada, H. 1982: Defective estrogen receptor in uteri of rats treated neonatally with a high dose of estrogen Nihon Sanka Fujinka Gakkai Zasshi 34(3): 391-395
Mori, T.; Morimoto, T.; Komaki, K.; Monden, Y. 1989: The receptor status between in primary tumor and in its involved regional node referring to estrogen receptor and epidermal growth factor receptor in human breast cancer: preliminary report Nihon Geka Gakkai Zasshi 90(10): 1820
Vickers, A.E.; Nelson, K.; McCoy, Z.; Lucier, G.W. 1989: Changes in estrogen receptor, DNA ploidy, and estrogen metabolism in rat hepatocytes during a two-stage model for hepatocarcinogenesis using 17 alpha-ethinylestradiol as the promoting agent Cancer Research 49(23): 6512-6520
Horvath, G.; Fernö, M.; Cameron, R.; Ranstam, J. 1989: Estrogen receptor activation in relation to previous estrogen treatment in carcinoma corporis uteri heterotransplanted into nude mice In Vivo 3(2): 93-97
Orajarvi, M.; Hirvonen, O.; Yu, S.-B.; Liu, X.; Tiilikainen, P.; Wang, M.; Raustia, A.; Pirttiniemi, P. 2011: Effect of estrogen and altered diet hardness on the expression of estrogen receptor alpha and matrix metalloproteinase-8 in rat condylar cartilage Journal of Orofacial Pain 25(3): 261-268
Martinez, E.; Wahli, W. 1989: Cooperative binding of estrogen receptor to imperfect estrogen-responsive DNA elements correlates with their synergistic hormone-dependent enhancer activity EMBO Journal 8(12): 3781-3791
Surowiak, P.; Dziegiel, P.; Zabel, M.; Matkowski, R.; Kornafel, J. 2001: Prognostic value of immunocytochemical estimation of estrogen receptor (ER) and of pS2 estrogen-dependent protein in cells of mammary ductal carcinoma. Analysis of five-year course of the disease Folia Histochemica et Cytobiologica 39(2): 143-144
Nielsen, S.T.; Dove, P.A.; Strike, D.P.; Schiehser, G.A. 1987: Structural modification of H2-receptor antagonists provide post-H2-receptor gastric antisecretory activity Drugs under Experimental and Clinical Research 13(5): 297-304
Daniels, A.J.; Matthews, J.E.; Viveros, O.H.; Leban, J.J.; Cory, M.; Heyer, D. 1995: Structure-activity relationship of novel pentapeptide neuropeptide y receptor antagonists is consistent with a noncontinuous epitope for ligand-receptor binding Molecular Pharmacology 48(3): 425-432